Log in to save to my catalogue

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Muc...

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Muc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1951ec02fb74365a4d7fe391d671752

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I

About this item

Full title

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I

Publisher

Switzerland: MDPI AG

Journal title

International journal of neonatal screening, 2020-03, Vol.6 (1), p.10-10

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Enzyme-based newborn screening for Mucopolysaccharidosis type I (MPS I) has a high false-positive rate due to the prevalence of pseudodeficiency alleles, often resulting in unnecessary and costly follow up. The glycosaminoglycans (GAGs), dermatan sulfate (DS) and heparan sulfate (HS) are both substrates for α-l-iduronidase (IDUA). These GAGs are el...

Alternative Titles

Full title

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d1951ec02fb74365a4d7fe391d671752

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1951ec02fb74365a4d7fe391d671752

Other Identifiers

ISSN

2409-515X

E-ISSN

2409-515X

DOI

10.3390/ijns6010010

How to access this item